Launched on July 28, 2020, XPRIZE Rapid Covid Testing is a $5 million, 6-month competition that aims to increase Covid-19 testing capabilities 100-times past our current standard, the level of increase needed to more safely return to everyday activities.
219 teams, including Biomeme, have moved on to the semi-finals after being assigned a “pass” by XPRIZE judges. We will be sent a blinded Proficiency Test Kit and be required to accurately identify which samples contain Covid-19. We will have one week to submit our results to the XPRIZE Data Collaborative, where results will be scored on specificity, sensitivity, and limits of detection.
Finalists will be announced October 23, 2020, and should Biomeme be one of them (🤞), we will have two weeks to send our testing kits and protocols to two separate laboratories for clinical validation. To ensure a fair competition with comparable results, samples within each lab will be split and tested across multiple tests.
A $1-million grand prize will be awarded to each of the top five teams that develop frequent, fast, cheap and easy Covid-19 screening solutions that help meet the surging demand for tests, and relieve the global supply chain. Final event details will be shared at a later date.
We are proud to be a semi-finalist of the XPRIZE Rapid Covid Testing Competition and would like to thank our magnificent team for their hard work and congratulate the other semi-finalists!
Stay tuned for more details.
XPRIZE, a 501(c)(3) nonprofit, is the global leader in designing and implementing innovative competition models to solve the world’s grandest challenges. Active competitions include the$20 Million NRG COSIA Carbon XPRIZE, the $10 Million Rainforest XPRIZE, the $10 Million ANA Avatar XPRIZE, the $5 Million IBM Watson AI XPRIZE, $5 Million XPRIZE Rapid Reskilling, XPRIZE NextGen Mask Challenge and $5 Million XPRIZE Rapid COVID Testing. For more information, visit xprize.org.
